Peter D Kwong

This inventor holds 51 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in HIV Vaccine Development. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Dana-Farber-Cancer Institute Inc., Columbia University. Active years: 2002-2025.

USPTO Granted Patents = 51 (Patent Applications = 7)

% Patents Active = 84.3

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 8.1

ph-index = 7

Forward Citations = 165(Granted Patents)

Forward Citations (Not Self Cited) = 148(Dec 10, 2025)

Location History:

New York, NY (US) (2002 - 2006)
Rockville, MD (US) (2018 - 2020)
Washington, DC (US) (2005 - 2024)

Company Filing History:

44 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

7 out of 1,265

Dana-Farber-Cancer Institute Inc.

Institute for Research in Biomedicine

patents

5. 4 out of 2,166

University of Washington

International Aids Vaccine Initiative

patents

9. 2 out of 5,497

Leland Stanford Junior University

patents

10. 2 out of 1,205

Scripps Research Institute

patents

11. 2 out of 2,651

University of Pennsylvania

patents

12. 1 out of 576

Los Alamos National Security, LLC

patents

13. 1 out of 641

The UAB Research Foundation (The University of Alabama at Birmingham)

patents

14. 1 out of 307

Triad National Security, LLC

patents

15. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

HIV-1 Antibodies

Prefusion RSV F Proteins

Influenza Hemagglutinin

Neutralizing Antibodies

Vaccine Immunogens

Recombinant Proteins

CD4-Binding Site

Infectious Disease

Antibody Evolution

Virus Fusion Peptides

Metapneumovirus

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275758 - Prefusion RSV F proteins and their use (2025-04-14),

2. 12268737 - Stabilized influenza hemagglutinin stem region trimers and uses thereof (2025-04-08),

3. 11878998 - Prefusion RSV F proteins and their use (2024-01-23),

4. 11845778 - Prefusion PIV F immunogens and their use (2023-12-19),

5. 11786591 - Recombinant metapneumovirus F proteins and their use (2023-10-17),

6. 11760790 - Neutralizing antibodies to HIV-1 Env and their use (2023-09-19),

7. 11602559 - HIV-1 Env fusion peptide immunogens and their use (2023-03-14),

8. 11591372 - Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof (2023-02-28),

9. 11459360 - Recombinant HIV-1 envelope proteins and their use (2022-10-04),

10. 11236152 - Neutralizing antibodies to HIV-1 GP41 and their use (2022-02-01),

11. 11174292 - Substitutions-modified prefusion RSV F proteins and their use (2021-11-16),

12. 11147867 - Stabilized influenza hemagglutinin stem region trimers and uses thereof (2021-10-19),

13. 11136356 - Recombinant HIV-1 envelope proteins and their use (2021-10-05),

14. 11130785 - Prefusion RSV F proteins and their use (2021-09-28),

15. 11078239 - Prefusion PIV F immunogens and their use (2021-08-03),

Title: The Innovative Mind of Peter D Kwong

Introduction:

Peter D Kwong is a renowned inventor based in New York, NY, known for his groundbreaking contributions to various fields through his innovative creations and patents.

Latest Patents:

Peter D Kwong holds several patents in the areas of technology and healthcare, with his most recent inventions focusing on advancements in artificial intelligence and medical devices.

Career Highlights:

With a career spanning over two decades, Peter D Kwong has established himself as a leading figure in the innovation landscape. His work has not only revolutionized industries but has also improved the quality of life for many individuals around the world.

Collaborations:

Throughout his career, Peter D Kwong has collaborated with top research institutions, leading companies, and brilliant minds in the field of technology and healthcare. These collaborations have resulted in the development of cutting-edge solutions that have set new standards in the industry.

Conclusion:

In conclusion, Peter D Kwong's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible.